e-learning
resources
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells
Sebastian Vencken, Camilla Foged, Joanne M. Ramsey, Louise Sweeney, Sally-Ann Cryan, Ronan J. MacLoughlin, Catherine M. Greene
Source:
ERJ Open Res, 5 (2) 00161-2018; 10.1183/23120541.00161-2018
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sebastian Vencken, Camilla Foged, Joanne M. Ramsey, Louise Sweeney, Sally-Ann Cryan, Ronan J. MacLoughlin, Catherine M. Greene. Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells. ERJ Open Res, 5 (2) 00161-2018; 10.1183/23120541.00161-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung
Source: Annual Congress 2009 - New drugs for airways disease
Year: 2009
Inflammatory and antioxidant effects of inhaled nanoparticles on human primary bronchial epithelial cells
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
Engineered nanoparticles induce apoptosis of human bronchial epithelial cells
Source: Annual Congress 2011 - Lung cell biology
Year: 2011
The antifibrotic effect of Imatinib loaded CD44 targeted gold nanoparticles (Im-CD44-GNP) relies on alveolar macrophage regulation
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Bioengineered nanoparticles targeted to mesenchymal cells from patients with BOS exert anti-inflammatory activity
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017
Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells
Source: Eur Respir J 2015; 45: 428-439
Year: 2015
Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of anti-fibrotic miR-142-3p
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
The physicochemical properties of nanoparticles determine the mechanism of uptake by human alveolar type I epithelial cells
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010
Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Diesel particle induces aging phenotype of bronchial epithelial cells via disruption of anti-aging molecule
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
Designed core-shell nanoparticles: intracellular localization and pro-inflammatory cytokine release in lung cells
Source: Annual Congress 2009 - Lung cell biology and immunology
Year: 2009
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
Effects of functionalised chalcones on pro-inflammatory mediator release from lung epithelial cells
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
Guaifenesin alters mucus rheology and improves mucociliary transport in human airway epithelial cell cultures: Comparison with N-acetylcysteine and ambroxol
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012
Tiotropium inhibits acetylcholine-induced generation of proinflammatory microparticles by human pulmonary epithelial cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2008 - Airway cell biology
Year: 2008
Intratracheal administration of dry powdered low-molecular-weight chitosan/siRNA complexes suppressed gene expression in the airway and metastatic tumors in murine lung
Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases
Year: 2012
Effect of inhaled surfactant enriched with phosphatidylethanolamine on matrix deposition in a murine model of airway inflammation and remodeling.
Source: International Congress 2018 – Basic pharmacology
Year: 2018
Aerosolised delivery of mesenchymal stromal cells to the lungs: towards a novel therapy
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept